Morning Market Losers By: Benzinga via Benzinga April 07, 2015 at 09:46 AM EDT Ocular Therapeutix, Inc. (NASDAQ: OCUL) shares fell 19.84% to $30.70 after the company issued topline clinical data for second Phase ... Read More >> Related Stocks: American Express General Motors Genesis Energy LP Ocular Therapeut Schnitzer Steel A Viacom